AA
ATXS

AQR Arbitrage’s Astria Therapeutics ATXS Stock Holding History

AQR Arbitrage’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-627,293
Closed -$8.21M – 559
2025
Q4 		$8.21M Buy
+627,293
New +$7.49M 0.17% 162

AQR Arbitrage's ATXS Position: Q1 2026 in Review

AQR Arbitrage sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 627,293 shares — an estimated $8.21M sold.

AQR Arbitrage first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $8.21M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

  • AQR Arbitrage reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AQR Arbitrage sold 627,293 Astria Therapeutics shares in Q1 2026, an estimated $8.21M.
  • AQR Arbitrage first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
  • AQR Arbitrage's Astria Therapeutics position peaked at $8.21M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.